OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
Joshua S. Frankel, Thomas L. Schwartz
Therapeutic Advances in Psychopharmacology (2016) Vol. 7, Iss. 1, pp. 29-41
Open Access | Times Cited: 109
Joshua S. Frankel, Thomas L. Schwartz
Therapeutic Advances in Psychopharmacology (2016) Vol. 7, Iss. 1, pp. 29-41
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 800
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 800
A perspective on multi‐target drug discovery and design for complex diseases
Rona R. Ramsay, Marija R. Popovic‐Nikolic, Katarina Nikolić, et al.
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 605
Rona R. Ramsay, Marija R. Popovic‐Nikolic, Katarina Nikolić, et al.
Clinical and Translational Medicine (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 605
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes
Stephen M. Stahl
CNS Spectrums (2017) Vol. 22, Iss. 5, pp. 375-384
Open Access | Times Cited: 225
Stephen M. Stahl
CNS Spectrums (2017) Vol. 22, Iss. 5, pp. 375-384
Open Access | Times Cited: 225
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Kristen M. Ward, Leslie Citrome
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 247-257
Open Access | Times Cited: 179
Kristen M. Ward, Leslie Citrome
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 247-257
Open Access | Times Cited: 179
Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry
Pratibha Yadav, Kamal Shah
Bioorganic Chemistry (2021) Vol. 109, pp. 104639-104639
Closed Access | Times Cited: 172
Pratibha Yadav, Kamal Shah
Bioorganic Chemistry (2021) Vol. 109, pp. 104639-104639
Closed Access | Times Cited: 172
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update
Massimo Carlo Mauri, Silvia Paletta, Chiara Di Pace, et al.
Clinical Pharmacokinetics (2018) Vol. 57, Iss. 12, pp. 1493-1528
Closed Access | Times Cited: 149
Massimo Carlo Mauri, Silvia Paletta, Chiara Di Pace, et al.
Clinical Pharmacokinetics (2018) Vol. 57, Iss. 12, pp. 1493-1528
Closed Access | Times Cited: 149
Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account
Tiago V. Maia, Vasco A. Conceição
Biological Psychiatry (2018) Vol. 84, Iss. 5, pp. 332-344
Closed Access | Times Cited: 117
Tiago V. Maia, Vasco A. Conceição
Biological Psychiatry (2018) Vol. 84, Iss. 5, pp. 332-344
Closed Access | Times Cited: 117
Tardive syndromes
Daniel Savitt, Joseph Jankovic
Journal of the Neurological Sciences (2018) Vol. 389, pp. 35-42
Closed Access | Times Cited: 93
Daniel Savitt, Joseph Jankovic
Journal of the Neurological Sciences (2018) Vol. 389, pp. 35-42
Closed Access | Times Cited: 93
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Structure, function and drug discovery of GPCR signaling
Lin Cheng, Fan Xia, Ziyan Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 29
Lin Cheng, Fan Xia, Ziyan Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 29
Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Erin W. Noye Tuplin, Matthew R. Holahan
Current Neuropharmacology (2017) Vol. 15, Iss. 8
Open Access | Times Cited: 83
Erin W. Noye Tuplin, Matthew R. Holahan
Current Neuropharmacology (2017) Vol. 15, Iss. 8
Open Access | Times Cited: 83
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
Nicholas A Keks, Judy Hope, Darren Schwartz, et al.
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 473-507
Closed Access | Times Cited: 51
Nicholas A Keks, Judy Hope, Darren Schwartz, et al.
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 473-507
Closed Access | Times Cited: 51
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice
Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 27, pp. 2241-2259
Closed Access | Times Cited: 28
Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 27, pp. 2241-2259
Closed Access | Times Cited: 28
Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa, et al.
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 397-397
Open Access | Times Cited: 20
Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa, et al.
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 397-397
Open Access | Times Cited: 20
Recent Advances in the Synthesis of Fused‐Cyclic Quinolines
Shahab A. Darbandizadeh, Saeed Balalaie
Asian Journal of Organic Chemistry (2024) Vol. 13, Iss. 5
Closed Access | Times Cited: 6
Shahab A. Darbandizadeh, Saeed Balalaie
Asian Journal of Organic Chemistry (2024) Vol. 13, Iss. 5
Closed Access | Times Cited: 6
Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review
Isra’ Zeiadeh, Anas Najjar, Rafik Karaman
Molecules (2018) Vol. 23, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 58
Isra’ Zeiadeh, Anas Najjar, Rafik Karaman
Molecules (2018) Vol. 23, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 58
The role of dopamine D3receptors in the mechanism of action of cariprazine
Francesca Calabrese, Frank I. Tarazi, Giorgio Racagni, et al.
CNS Spectrums (2019) Vol. 25, Iss. 3, pp. 343-351
Open Access | Times Cited: 52
Francesca Calabrese, Frank I. Tarazi, Giorgio Racagni, et al.
CNS Spectrums (2019) Vol. 25, Iss. 3, pp. 343-351
Open Access | Times Cited: 52
Up-to-date expert opinion on the safety of recently developed antipsychotics
Laura Orsolini, Domenico De Berardis, Umberto Volpe
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 981-998
Closed Access | Times Cited: 48
Laura Orsolini, Domenico De Berardis, Umberto Volpe
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 981-998
Closed Access | Times Cited: 48
Brexpiprazole: A Review in Schizophrenia
James E. Frampton
Drugs (2019) Vol. 79, Iss. 2, pp. 189-200
Closed Access | Times Cited: 47
James E. Frampton
Drugs (2019) Vol. 79, Iss. 2, pp. 189-200
Closed Access | Times Cited: 47
Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
Pavel Mohr, Jiří Masopust, Miloslav Kopeček
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 27
Pavel Mohr, Jiří Masopust, Miloslav Kopeček
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 27
Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling
D. Kavindi Weerasinghe, Jason M. Hodge, Julie A. Pasco, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
D. Kavindi Weerasinghe, Jason M. Hodge, Julie A. Pasco, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction
Shuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 947-947
Open Access | Times Cited: 36
Shuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 947-947
Open Access | Times Cited: 36
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney, Dominic Oliver, Philip McGuire
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1179-1190
Open Access | Times Cited: 32
Edward Chesney, Dominic Oliver, Philip McGuire
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1179-1190
Open Access | Times Cited: 32
Highly sensitive electrochemical determination of cariprazine using a novel Ti3C2@CoAl2O4 nanocomposite: application to pharmaceutical and biological sample analysis
Elif Naz Öven, Asena Ayşe Genç, Nevin Erk, et al.
Microchimica Acta (2025) Vol. 192, Iss. 4
Open Access
Elif Naz Öven, Asena Ayşe Genç, Nevin Erk, et al.
Microchimica Acta (2025) Vol. 192, Iss. 4
Open Access
The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis
Bing Bai, Yuwei Li, Xi Chen, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Bing Bai, Yuwei Li, Xi Chen, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
